Patents Assigned to UCB, S.A./N.V.
  • Patent number: 6727275
    Abstract: The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1 or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: April 27, 2004
    Assignee: UCB, S.A./N.V.
    Inventors: Dong Zou, Olivier Dasse, Janelle Evans, Paul Higgins, Jeremy Kintigh, Rama Kondru, Eric Schwartz, Laurent Knerr, Hai-Xiao Zhai